Hypersensitivity reaction to epirubicin
- PMID: 2615533
- DOI: 10.1007/BF02985165
Hypersensitivity reaction to epirubicin
Abstract
A patient with metastatic breast cancer treated with epirubicin (Pharmorubicin) developed a severe urticarial reaction which progressed to ulceration following possible sensitisation to the drug by preceding extravasation.
References
-
- J Clin Oncol. 1986 Mar;4(3):425-39 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical